30 October 2026
On 29 October 2026, Louisa Ghevaert was delighted to attend The Biobridge Foundation’s Women’s Health Forum at Home House Studio in Marylebone. This invitation-only event welcomed leading UK and international clinicians, researchers, scientists, policy and advisory experts for an evening dedicated to women’s health and engagement over a three-course dinner. It fostered meaningful perspectives about reproductive medicine, women’s intimate health and regenerative medicine.
Images: Dr Greta Peciulyte Consultant Urologist, Aesthetic & Regenerative Andrologist & Founder of L’Homme Inti Clinic in London, Dr Sarah Berndt, PhD Biomedical and Pharmaceutical Sciences Head of Department at Regen Lab, Louisa Ghevaert, CEO & Founder Louisa Ghevaert Associates
The Forum facilitated informative multi-disciplinary discussions about women’s health and formed part of The BioBridge Foundation’s UK and Northern Europe 2026 – 2027 Educational Season. It addressed evolving developments in regenerative medicine, reproductive innovation, current and future clinical practice. In doing so, it looked at advances in stem-cell and exome research studies and how these developments can be translated from scientific research into evidence-based medical practice. It also provided valuable real-life clinical insights into Platelet-Rich Plasma (PRP) innovation in reproductive medicine and patient care to help improve women’s health.
Images: Dr Pascal Mock Specialist in Gynaecology and Reproductive Medicine and Gynecological Endocrinology, In Vivo Clinic Geneva, Dr Sarah Berndt, PhD Biomedical and Pharmaceutical Sciences Head of Department at Regen Lab
Dr Sarah Berndt, PhD, delivered an insightful talk on PRP preparations, biology, standardisation and evidence which included reproducibility and responsible clinical use. Dr Farzana Khan then gave a compelling talk on regenerative approaches to women’s intimate health and clinical presentation and care of Lichen sclerosus which is a chronic inflammatory condition that affects anatomy, sexual wellbeing and quality of life.
This event also acknowledged Breast Cancer Awareness Month and the importance of women’s health from early diagnosis, to equitable access to care, life after cancer treatment, intimate wellbeing and quality of life. In doing so, it recognised the impact of surgery and chemotherapy on women’s intimate health and the benefits of PRP for women whose cancer treatment has triggered early menopause and who are unable to take Hormone Replacement Therapy (HRT) for medical reasons. Breast cancer remains the second most common type of cancer in the UK.
Need Advisory or a Fertility Lawyer?
Pre-conception management, fertility preservation, evolving reproductive and fertility treatments, together with modern family building create complex issues from a medical, legal and logistical perspective. As such, effective legal and practical strategies play an important role in navigating and optimising preconception and fertility, pregnancy, birth, family life during and after death.
To find our more about our expert advisory and consultancy click here.
To find out more about our law and policy expertise click here.
To find out more about genomics, genetics and fertility law click here.
To find our more about fertility preservation law click here.
To find out more about fertility treatment law click here.
To find out more about family building options and law click here.
To find out more about transgender fertility and family law click here.
To find out more about posthumous conception law click here.
